114 related articles for article (PubMed ID: 19019622)
1. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells.
Kubarek Ł; Jagodzinski PP
FEBS Lett; 2007 Apr; 581(7):1441-8. PubMed ID: 17362937
[TBL] [Abstract][Full Text] [Related]
3. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines.
Sowińska A; Jagodzinski PP
Cancer Lett; 2007 Sep; 255(1):153-9. PubMed ID: 17532557
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells.
Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2010 Jan; 64(1):54-7. PubMed ID: 19748759
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
6. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M
Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272
[TBL] [Abstract][Full Text] [Related]
7. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
8. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
Przybylski M; Kozłowska A; Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
Biomed Pharmacother; 2010 Apr; 64(4):254-8. PubMed ID: 19932585
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
11. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
Wang J; Bhutani M; Pathak AK; Lang W; Ren H; Jelinek J; He R; Shen L; Issa JP; Mao L
Cancer Res; 2007 Nov; 67(22):10647-52. PubMed ID: 18006804
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma.
Luczak MW; Roszak A; Pawlik P; Kędzia H; Kędzia W; Malkowska-Walczak B; Lianeri M; Jagodziński PP
Int J Oncol; 2012 Mar; 40(3):860-6. PubMed ID: 21887463
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells.
Bolanz KA; Kovacs GG; Landowski CP; Hediger MA
Mol Cancer Res; 2009 Dec; 7(12):2000-10. PubMed ID: 19996302
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
[TBL] [Abstract][Full Text] [Related]
17. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
[TBL] [Abstract][Full Text] [Related]
18. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
19. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
